Who Paid My Doc
Concertotm
Device Vascular Embolization
PDI 00847536033481
General payments
$539,166
Research payments
$1,693,268
Through program year 2025, $539,166 in general payments and $1,693,268 in research payments were reported against Concertotm (Vascular Embolization).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $170,095 | 1,141 |
| 2024 | General | $107,960 | 1,190 |
| 2024 | Research | $687,901 | 211 |
| 2023 | General | $136,350 | 1,184 |
| 2023 | Research | $696,732 | 179 |
| 2022 | General | $124,761 | 1,391 |
| 2022 | Research | $308,635 | 79 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,906 general · 469 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.